1. Home
  2. GSK vs SYK Comparison

GSK vs SYK Comparison

Compare GSK & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GSK plc (Each representing two)

GSK

GSK plc (Each representing two)

HOLD

Current Price

$57.91

Market Cap

116.3B

Sector

Health Care

ML Signal

HOLD

Logo Stryker Corporation

SYK

Stryker Corporation

HOLD

Current Price

$341.70

Market Cap

127.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSK
SYK
Founded
1715
1941
Country
United Kingdom
United States
Employees
66841
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
116.3B
127.0B
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
GSK
SYK
Price
$57.91
$341.70
Analyst Decision
Buy
Buy
Analyst Count
2
14
Target Price
N/A
$416.43
AVG Volume (30 Days)
3.9M
1.9M
Earning Date
04-29-2026
04-30-2026
Dividend Yield
2.95%
1.02%
EPS Growth
N/A
8.25
EPS
N/A
8.40
Revenue
N/A
$25,116,000,000.00
Revenue This Year
$6.70
$9.85
Revenue Next Year
$4.22
$8.36
P/E Ratio
$32.75
$41.23
Revenue Growth
N/A
11.16
52 Week Low
$35.08
$319.32
52 Week High
$61.70
$404.87

Technical Indicators

Market Signals
Indicator
GSK
SYK
Relative Strength Index (RSI) 59.04 49.15
Support Level $47.89 $328.23
Resistance Level $60.37 $375.26
Average True Range (ATR) 1.04 7.56
MACD 0.45 2.80
Stochastic Oscillator 70.76 67.26

Price Performance

Historical Comparison
GSK
SYK

About GSK GSK plc (Each representing two)

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

About SYK Stryker Corporation

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.

Share on Social Networks: